Siemens (NYSE:SI) won FDA clearance for its latest MRI imaging system, the Magnetom Spectra 3 Tesla device.
The system aims to offer premium images with a lower financial footprint compared to other similar scanners, while providing "highly coveted" 3 Tesla technology for high-quality scans at faster speeds.
"The Magnetom Spectra delivers crisp, high-resolution images that provide the key to a new level of usability and diagnostic confidence for physicians," MR vice president Ioannis Panagiotelis said in prepared remarks.
The device fits into Siemens 2013 agenda for devices that are primarily innovative and competitive, according to a company statement.
It employs total imaging matrix technology for imaging accuracy and flexibility, high spatial and temporal resolution and a high signal-to-noise ratio, according to a press release.
The device also boasts a lower energy footprint and can be used in a broad range of applications, from diagnosing damaged ankle cartilage to functional brain imaging.
